Publication | Closed Access
Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study
11
Citations
0
References
2006
Year
Unknown Venue
ThrombosisVenous ThrombosisCardiovascular DiseaseOdixa-dvt Dose-ranging StudyBay 59-7939PharmacologyHematologyPharmacotherapyCoagulopathyMedicineAnticoagulantAtherosclerosis
No additional data available for this publication yet. Check back later!